BIOSGN — Biosergen AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK40.77m
- SEK37.53m
Annual cashflow statement for Biosergen AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -34.1 | -34.1 | -27.3 | -19.2 | -38 |
| Non-Cash Items | -0.24 | 0.081 | — | 0.008 | 0.03 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.43 | 4.61 | -5.49 | 9.02 | 1.2 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -37.7 | -29.4 | -32.8 | -10.2 | -36.8 |
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 58.8 | 37.1 | 5.3 | 58.9 | -0.038 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 21.1 | 7.68 | -27.5 | 48.7 | -35.2 |